| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1076/OCII.11.2.79.15918 |
| P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.1076/ocii.11.2.79.15918 |
| P698 | PubMed publication ID | 14533026 |
| P2093 | author name string | Richard Stawell | |
| P2860 | cites work | Investigative Ophthalmology Visual Science | Q6060707 |
| The Journal of Rheumatology | Q7743623 | ||
| Molecular action of methotrexate in inflammatory diseases | Q24534771 | ||
| Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology | Q27713630 | ||
| Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update | Q28324515 | ||
| Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. | Q33920749 | ||
| Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid | Q34853520 | ||
| The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis | Q41200879 | ||
| Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain | Q42449538 | ||
| Use of methotrexate in the management of sight-threatening uveitis | Q43550379 | ||
| Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group | Q44719227 | ||
| Low-dose methotrexate therapy for ocular inflammatory disease | Q45693995 | ||
| Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. | Q53793714 | ||
| Efficacy of low-dose methotrexate in rheumatoid arthritis | Q69884411 | ||
| Clinical features and prognosis in Fuchs' uveitis syndrome | Q71841585 | ||
| Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management | Q72051049 | ||
| Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology | Q72296676 | ||
| Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients | Q73947310 | ||
| EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS. I. THE EFFECT OF DEXAMETHASONE IN THE NORMAL EYE | Q76603787 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ophthalmology | Q161437 |
| methotrexate | Q422232 | ||
| eye disease | Q3041498 | ||
| P304 | page(s) | 79-82 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Ocular Immunology and Inflammation | Q15760486 |
| P1476 | title | Methotrexate in inflammatory eye disease | |
| P478 | volume | 11 |
| Q34770054 | A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers |
| Q42488257 | Anticancer agents against malaria: time to revisit? |
| Q42341510 | Challenges with cataract surgery in pars planitis patients. |
Search more.